Clinical Trial Update: Ph II Early BC Pre-Surgical Biologic Study [Phase 2]

View source ↗

Summary

Phase II study in breast cancer evaluating an early pre-surgical biologic approach has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED